{"transactions":[{"id":819041,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:20:14.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the one year period beginning March 31, 2026."}],"balance_after":75000,"derivative":{"exercise_price":0.615,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001628280-26-023354","document":"wk-form4_1775168412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026023354/wk-form4_1775168412.xml","form_type":"4"}},{"id":876501,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2026-02-27T21:30:09.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":106848,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":106848,"derivative":{"underlying":"American Depository Shares","underlying_shares":106848},"source":{"system":"sec-edgar","filing":"0001193125-26-082835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000119312526082835/ownership.xml","form_type":"4"}},{"id":876500,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to buy)","published_at":"2026-02-27T21:30:09.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":66000,"derivative":{"exercise_price":0.39,"expiration_date":"2036-02-26","underlying":"American Depositary Shares","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0001193125-26-082835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000119312526082835/ownership.xml","form_type":"4"}},{"id":914143,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T01:54:28.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the one-year period beginning January 19, 2026."}],"balance_after":35000,"derivative":{"exercise_price":0.82,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001628280-26-006621","document":"wk-form4_1770688465.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026006621/wk-form4_1770688465.xml","form_type":"4"}},{"id":1111860,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-06-13T12:16:45.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":26000,"derivative":{"exercise_price":4.52,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Ordinary Shares","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001816590-25-000069","document":"wk-form4_1749816998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659025000069/wk-form4_1749816998.xml","form_type":"4"}},{"id":1242521,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-26T22:51:47.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the one year period beginning February 21, 2025."}],"balance_after":35000,"derivative":{"exercise_price":2.89,"expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001516551-25-000016","document":"wk-form4_1740610301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655125000016/wk-form4_1740610301.xml","form_type":"4"}},{"id":1280004,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2025-02-06T21:30:05.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":15243,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer"}],"balance_after":15243,"derivative":{"underlying":"American Depository Shares","underlying_shares":15243},"source":{"system":"sec-edgar","filing":"0000950170-25-015417","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000095017025015417/ownership.xml","form_type":"4"}},{"id":1280003,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to buy)","published_at":"2025-02-06T21:30:05.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date"},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer"}],"balance_after":55000,"derivative":{"exercise_price":3.16,"expiration_date":"2035-02-05","underlying":"American Depositary Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000950170-25-015417","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000095017025015417/ownership.xml","form_type":"4"}},{"id":1379291,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-31T00:25:01.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the one year period beginning October 28, 2024."}],"balance_after":70000,"derivative":{"exercise_price":5.15,"expiration_date":"2034-10-27","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001516551-24-000096","document":"wk-form4_1730334295.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655124000096/wk-form4_1730334295.xml","form_type":"4"}},{"id":1440943,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-05T12:28:13.000Z","date":"2024-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":161,"price":6.88,"value":1107.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."}],"balance_after":19480,"source":{"system":"sec-edgar","filing":"0001628280-24-034539","document":"wk-form4_1722860886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000162828024034539/wk-form4_1722860886.xml","form_type":"4"}},{"id":1519156,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-05-13T10:45:16.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":26000,"derivative":{"exercise_price":8.54,"exercise_date":"2025-05-09","expiration_date":"2034-05-08","underlying":"Ordinary Shares","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001816590-24-000097","document":"wk-form4_1715597104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659024000097/wk-form4_1715597104.xml","form_type":"4"}},{"id":1528501,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-03T12:13:12.000Z","date":"2024-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":211,"price":8.48,"value":1789.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."}],"balance_after":19641,"source":{"system":"sec-edgar","filing":"0001816590-24-000077","document":"wk-form4_1714738380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659024000077/wk-form4_1714738380.xml","form_type":"4"}},{"id":1602496,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T23:01:09.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $14.56 per option share for ten years from February 29, 2024 and the options will vest in equal monthly installments over the one year period beginning February 29, 2024."}],"balance_after":40000,"derivative":{"exercise_price":14.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001516551-24-000038","document":"wk-form4_1709593247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655124000038/wk-form4_1709593247.xml","form_type":"4"}},{"id":1651172,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2024-02-09T21:15:14.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":14947,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":14947,"derivative":{"underlying":"American Depository Shares","underlying_shares":14947},"source":{"system":"sec-edgar","filing":"0000950170-24-013273","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000095017024013273/ownership.xml","form_type":"4"}},{"id":1651171,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to buy)","published_at":"2024-02-09T21:15:14.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in substantially equal monthly installments over a one year period from the February 8, 2024 grant date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":3.87,"expiration_date":"2034-02-08","underlying":"American Depository Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000950170-24-013273","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000095017024013273/ownership.xml","form_type":"4"}},{"id":1659125,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-02-05T22:10:10.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":175,"price":11.34,"value":1984.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."}],"balance_after":19852,"source":{"system":"sec-edgar","filing":"0001816590-24-000026","document":"wk-form4_1707170969.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659024000026/wk-form4_1707170969.xml","form_type":"4"}},{"id":1751453,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-11-02T13:06:52.000Z","date":"2023-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":143,"price":5.78,"value":826.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."}],"balance_after":20027,"source":{"system":"sec-edgar","filing":"0001816590-23-000137","document":"wk-form4_1698930397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659023000137/wk-form4_1698930397.xml","form_type":"4"}},{"id":1816560,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-03T22:50:51.000Z","date":"2023-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":161,"price":8.95,"value":1440.95,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."}],"balance_after":20170,"source":{"system":"sec-edgar","filing":"0001816590-23-000095","document":"wk-form4_1691103039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659023000095/wk-form4_1691103039.xml","form_type":"4"}},{"id":1861740,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:26:42.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":17643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 6, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17643,"derivative":{"exercise_price":1.09,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":17643},"source":{"system":"sec-edgar","filing":"0001127602-23-018282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000112760223018282/form4.xml","form_type":"4"}},{"id":1865285,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-06-06T20:23:53.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual Meeting of Shareholders in 2024."}],"balance_after":26000,"derivative":{"exercise_price":7.88,"exercise_date":"2024-06-02","expiration_date":"2033-06-01","underlying":"Ordinary Shares","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001816590-23-000085","document":"wk-form4_1686083021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659023000085/wk-form4_1686083021.xml","form_type":"4"}},{"id":1904548,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-04T12:25:32.000Z","date":"2023-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":25,"price":7.97,"value":199.25,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."}],"balance_after":20331,"source":{"system":"sec-edgar","filing":"0001816590-23-000067","document":"wf-form4_168320312036793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659023000067/wf-form4_168320312036793.xml","form_type":"4"}},{"id":2228099,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-06-17T20:08:30.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual Meeting of Shareholders in 2023."}],"balance_after":17000,"derivative":{"exercise_price":9.41,"expiration_date":"2032-06-15","underlying":"Ordinary Shares","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001816590-22-000056","document":"wf-form4_165549647968752.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659022000056/wf-form4_165549647968752.xml","form_type":"4"}},{"id":2235315,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:38:03.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":17478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17478,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":17478},"source":{"system":"sec-edgar","filing":"0001127602-22-017242","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000112760222017242/form4.xml","form_type":"4"}},{"id":2235314,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:38:03.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":17478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17478,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":17478},"source":{"system":"sec-edgar","filing":"0001127602-22-017242","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000112760222017242/form4.xml","form_type":"4"}},{"id":2313047,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-03-31T18:09:39.000Z","date":"2022-03-29","kind":"sale","acquired":false,"shares":3384,"price":12.48,"value":42232.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold to satisfy payment of a tax liability upon Restricted Share Units (\"RSUs\") vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 23,740 RSUs granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. 25% of the RSUs vested on August 12,2021, with the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":20356,"source":{"system":"sec-edgar","filing":"0001816590-22-000016","document":"wf-form4_164875016391913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659022000016/wf-form4_164875016391913.xml","form_type":"4"}},{"id":2657242,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-06-24T01:50:07.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest and become exercisable in four equal quarterly installments on June 30, 2021, September 30, 2021, December 31, 2021, and March 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter."}],"balance_after":65000,"derivative":{"exercise_price":1.48,"expiration_date":"2031-06-20","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-21-042896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121042896/doc4.xml","form_type":"4"}},{"id":2669629,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T21:40:04.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":17438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 10, 2022 or the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17438,"derivative":{"exercise_price":9.63,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":17438},"source":{"system":"sec-edgar","filing":"0001127602-21-019820","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000112760221019820/form4.xml","form_type":"4"}},{"id":3119845,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T21:13:47.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 4, 2021 or the date of the Issuer's 2021 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":21.91,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001127602-20-019020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000112760220019020/form4.xml","form_type":"4"}},{"id":3487622,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T20:31:04.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.74,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-19-013480","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761919013480/doc1.xml","form_type":"4"}},{"id":3487621,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T20:31:04.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":20072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program.  The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":33471,"source":{"system":"sec-edgar","filing":"0001567619-19-013480","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761919013480/doc1.xml","form_type":"4"}},{"id":3490858,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T21:09:14.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":9675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The  option shall vest in full upon the earlier of June 11, 2020 or the date of the Issuer's 2020 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":9675,"derivative":{"exercise_price":13.6,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":9675},"source":{"system":"sec-edgar","filing":"0000899243-19-016855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639481/000089924319016855/doc4.xml","form_type":"4"}},{"id":3597259,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-03-13T20:09:05.000Z","date":"2019-03-11","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will become exercisable in four equal quarterly installments from the date of grant on March 11, 2019 provided that the grantee remains a director on the last day of the applicable calendar quarter."}],"balance_after":100000,"derivative":{"exercise_price":4.28,"expiration_date":"2029-03-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000908662-19-000093","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000090866219000093/edgar.xml","form_type":"4"}},{"id":3892490,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T23:08:52.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.03,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-18-028865","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000114036118028865/doc1.xml","form_type":"4"}},{"id":3892489,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T23:08:52.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":13399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":13399,"source":{"system":"sec-edgar","filing":"0001140361-18-028865","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000114036118028865/doc1.xml","form_type":"4"}},{"id":4169903,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T17:08:20.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This option, which vests on December 31, 2018, subject to the Reporting Person's continued service to the Issuer on such date, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which vests on December 31, 2018, subject to the Reporting Person's continued service to the Issuer on such date, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2027-07-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-059629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117059629/doc4.xml","form_type":"4"}},{"id":4169902,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T17:08:20.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":192000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This stock option, which vests in 48 equal monthly installments beginning January 18, 2017, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option, which vests in 48 equal monthly installments beginning January 18, 2017, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.9,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":192000},"source":{"system":"sec-edgar","filing":"0001209191-17-059629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117059629/doc4.xml","form_type":"4"}},{"id":4169901,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T17:08:20.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":160000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This stock option, which vests in 48 equal monthly installments beginning January 28, 2016, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option, which vests in 48 equal monthly installments beginning January 28, 2016, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":7.14,"expiration_date":"2026-01-31","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001209191-17-059629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117059629/doc4.xml","form_type":"4"}},{"id":4169900,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T17:08:20.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":342113,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This stock option, which vests over four years beginning June 3, 2015, at a rate of 6.25% on September 23, 2015, and in 45 equal monthly installments thereafter, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option, which vests over four years beginning June 3, 2015, at a rate of 6.25% on September 23, 2015, and in 45 equal monthly installments thereafter, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":4.09,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":342113},"source":{"system":"sec-edgar","filing":"0001209191-17-059629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117059629/doc4.xml","form_type":"4"}},{"id":4169899,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T17:08:20.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":74375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This stock option, which vests over four years beginning September 23, 2014, at a rate of 25% after 12 months, and in 36 equal monthly installments thereafter, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option, which vests over four years beginning September 23, 2014, at a rate of 25% after 12 months, and in 36 equal monthly installments thereafter, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":3.57,"expiration_date":"2025-04-28","underlying":"Common Stock","underlying_shares":74375},"source":{"system":"sec-edgar","filing":"0001209191-17-059629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117059629/doc4.xml","form_type":"4"}},{"id":4169898,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T17:08:20.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":481696,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option, which vests over four years beginning September 23, 2014, at a rate of 25% after 12 months, and in 36 equal monthly installments thereafter, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option, which vests over four years beginning September 23, 2014, at a rate of 25% after 12 months, and in 36 equal monthly installments thereafter, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."}],"balance_after":0,"derivative":{"exercise_price":0.56,"expiration_date":"2024-09-24","underlying":"Common Stock","underlying_shares":481696},"source":{"system":"sec-edgar","filing":"0001209191-17-059629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117059629/doc4.xml","form_type":"4"}},{"id":4217799,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-05T06:18:38.000Z","date":"2017-09-05","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Vesting in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":100000,"derivative":{"exercise_price":0.979,"expiration_date":"2027-09-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-17-010200","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315217010200/form4.xml","form_type":"4"}},{"id":4263237,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-05T17:47:54.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest on December 31, 2018, subject to the Reporting Person's continued service to the Issuer on such date."}],"balance_after":150000,"derivative":{"exercise_price":1.35,"expiration_date":"2027-07-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-043425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117043425/doc4.xml","form_type":"4"}},{"id":4285456,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T16:26:08.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.3,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-17-024640","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000114036117024640/doc1.xml","form_type":"4"}},{"id":4467839,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":54212,"kind":"person","name":"Jenkins Annalisa","position":1,"cik":"0001639481","reported_name":"Jenkins Annalisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-03T16:52:35.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":192000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in forty-eight (48) equal monthly installments beginning on January 18, 2017."}],"balance_after":192000,"derivative":{"exercise_price":1.9,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":192000},"source":{"system":"sec-edgar","filing":"0001209191-17-007681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117007681/doc4.xml","form_type":"4"}}]}